SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-001417
Filing Date
2021-10-05
Accepted
2021-10-05 17:01:29
Documents
12
Period of Report
2021-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 e620993_8k-at.htm   iXBRL 8-K 23185
  Complete submission text file 0001193805-21-001417.txt   195111

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arct-20210929.xsd EX-101.SCH 3031
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20210929_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20210929_pre.xml EX-101.PRE 22363
5 EXTRACTED XBRL INSTANCE DOCUMENT e620993_8k-at_htm.xml XML 3626
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 211307538
SIC: 2834 Pharmaceutical Preparations